About Us
How we define Theripion:
Our company identity
We are an emerging biopharmaceutical company comprised of proven leaders in research, drug discovery and business operations with over 75 years of combined industry experience. We focus on the discovery of transformative therapies that, in collaboration with leading pharmaceutical companies, can efficiently deliver real solutions for the benefit of patients with unmet medical needs.
Our Vision
To discover and invent innovative biopharmaceuticals that empower patients to live their lives to the fullest.
Our Mission
To discover breakthrough therapeutics with clinically superior safety and efficacy attributes over existing treatments.
Our Goal
To be a leader in the discovery and early development of tomorrow’s biotherapeutics.
Our technology has direct applicability in diseases with significant morbidity and mortality. Our goal is to use our platform to develop therapies that rescue patients from the threat of some of the most debilitating diseases known to man.
Below is a table of target candidates for clinical trials.
| Fusion Protein | Description | Disease Target |
| TR-43 | Fc-PON 1 | Ischemia-Reperfusion Injury Cardiovascular Disease Inflammatory Bowel Disease Cystic Fibrosis Rheumatoid Arthritis Neurodegenerative Diseases |
| TR-45 | CTLA4-Fc-PON 1 | Rheumatoid Arthritis |
| THER-4 | ApoA-1-Fc | Alzheimer’s Disease Cardiovascular Disease |